The prognostic significance of BAP1, NF2, and CDKN2A in malignant peritoneal mesothelioma

The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma

Matthew J. Bott, Marie Brevet, Barry S. Taylor et al. · Nature Genetics · 2011 · 731 citations

Medicine, Cancer Biology, Oncology +15

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma: Multi-Institutional Experience

Tristan D. Yan, Marcello Deraco, Dario Baratti et al. · Journal of Clinical Oncology · 2009 · 685 citations · Full text

Medicine, Oncology, Surgery +13

High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas.

A. Bianchi, Shin‐ichiro Mitsunaga, J Q Cheng et al. · Proceedings of the National Academy of Sciences · 1995 · 366 citations · Full text

Medicine, Genetics, Oncology +16

Analysis of Factors Associated With Outcome in Patients With Malignant Peritoneal Mesothelioma Undergoing Surgical Debulking and Intraperitoneal Chemotherapy

Andrew L. Feldman, Steven K. Libutti, James F. Pingpank et al. · Journal of Clinical Oncology · 2003 · 352 citations

Medicine, Oncology, Surgery +12

p16 alterations and deletion mapping of 9p21-p22 in malignant mesothelioma.

Jin Cheng, S C Jhanwar, Willemijn M. Klein et al. · PubMed · 1994 · 325 citations

Veterinary Medicine, Genetics, Oncology +10